IMS in BHU will study use of Ashwagandha as a test drug for prophylactic use among frontline health workers and Yashtimadhu for supplementary therapy as a standard treatment of Corona patients
The Institute of Medical Sciences (IMS) in the Banaras Hindu University (BHU) will study the use of Ashwagandha (Withania somnifera) as a test drug for prophylactic use among frontline health workers and Yashtimadhu (Glycyrrhiza glabra) for supplementary therapy as a standard treatment of Corona patients with mild and moderate symptoms.
According to Professor Anand Chaudhary, head of the department of Rasa Shastra, of Ayurveda faculty IMS-BHU and centre coordinator for the project, “As a part of the project of ministry of AYUSH, Indian Council of Medical Research and Council of Scientific and Industrial Research, the university was assigned the task of conducting studies on Ashwagandha and Yashtimadhu.”
He said, “Ashwagandha will be tested for study in prophylactic use among frontline health workers of SSL Hospital of BHU and other healthcare workers, while Yashtimadhu will be tested as drug for adjunct therapy with the standard treatment of conventional medicine on Covid-19 patients under treatment in BHU with mild and moderate symptoms.”
No comments:
Post a Comment